Industry Research Reports

Home > Reports > Chemical & Material > Semi-Solid Dose- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Semi-Solid Dose- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published Date: 2026-02-01

Pages: 105 Pages

Report ld: 5855763

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Semi-Solid Dose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Semi-Solid Dose cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

A type of medication that is neither solid nor liquid; they are somewhere in between the two states.

The North American market for Semi-Solid Dose was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Semi-Solid Dose was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Semi-Solid Dose was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Semi-Solid Dose market include Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG, GlaxoSmithKline plc, Bausch Health Companies, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Semi-Solid Dose, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Semi-Solid Dose market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Semi-Solid Dose.

MARKET SEGMENTATION

By Company

Johnson & Johnson
Merck & Co
Bayer AG
Hisamitsu Pharmaceutical
Glenmark Pharmaceuticals
Cipla Ltd
Nestle SA
Novartis AG
GlaxoSmithKline plc
Bausch Health Companies

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Ointments
Pastes
Gels

Segment by Application

Skin
Nasal Cavity
Vaginal Cavity
Rectal Cavity
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Semi-Solid Dose manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Semi-Solid Dose sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Semi-Solid Dose sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Semi-Solid Dose Product Introduction

1.2 Global Semi-Solid Dose Market Size Forecast

1.2.1 Global Semi-Solid Dose Sales Value (2021–2032)

1.2.2 Global Semi-Solid Dose Sales Volume (2021–2032)

1.2.3 Global Semi-Solid Dose Sales Price (2021–2032)

1.3 Semi-Solid Dose Market Trends & Drivers

1.3.1 Semi-Solid Dose Industry Trends

1.3.2 Semi-Solid Dose Market Drivers & Opportunities

1.3.3 Semi-Solid Dose Market Challenges

1.3.4 Semi-Solid Dose Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Semi-Solid Dose Players Revenue Ranking (2025)

2.2 Global Semi-Solid Dose Revenue by Company (2021–2026)

2.3 Global Semi-Solid Dose Sales Volume Ranking of Players (2025)

2.4 Global Semi-Solid Dose Sales Volume by Company (2021–2026)

2.5 Global Semi-Solid Dose Average Price by Company (2021–2026)

2.6 Key Manufacturers Semi-Solid Dose Manufacturing Base and Headquarters

2.7 Key Manufacturers Semi-Solid Dose Product Offerings

2.8 Key Manufacturers Start of Mass Production of Semi-Solid Dose

2.9 Semi-Solid Dose Market Competitive Analysis

2.9.1 Semi-Solid Dose Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Semi-Solid Dose Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Semi-Solid Dose revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Semi-Solid Dose Market Classification

3.1 Introduction by Type

3.1.1 Ointments

3.1.2 Pastes

3.1.3 Gels

3.1.4 Global Semi-Solid Dose Sales Value by Type

3.1.4.1 Global Semi-Solid Dose Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Semi-Solid Dose Sales Value, by Type (2021–2032)

3.1.4.3 Global Semi-Solid Dose Sales Value, by Type (%), 2021–2032

3.1.5 Global Semi-Solid Dose Sales Volume by Type

3.1.5.1 Global Semi-Solid Dose Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Semi-Solid Dose Sales Volume, by Type (2021–2032)

3.1.5.3 Global Semi-Solid Dose Sales Volume, by Type (%), 2021–2032

3.1.6 Global Semi-Solid Dose Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Skin

4.1.2 Nasal Cavity

4.1.3 Vaginal Cavity

4.1.4 Rectal Cavity

4.1.5 Others

4.2 Global Semi-Solid Dose Sales Value by Application

4.2.1 Global Semi-Solid Dose Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Semi-Solid Dose Sales Value, by Application (2021–2032)

4.2.3 Global Semi-Solid Dose Sales Value, by Application (%), 2021–2032

4.3 Global Semi-Solid Dose Sales Volume by Application

4.3.1 Global Semi-Solid Dose Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Semi-Solid Dose Sales Volume, by Application (2021–2032)

4.3.3 Global Semi-Solid Dose Sales Volume, by Application (%), 2021–2032

4.4 Global Semi-Solid Dose Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Semi-Solid Dose Sales Value by Region

5.1.1 Global Semi-Solid Dose Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Semi-Solid Dose Sales Value by Region (2021–2026)

5.1.3 Global Semi-Solid Dose Sales Value by Region (2027–2032)

5.1.4 Global Semi-Solid Dose Sales Value by Region (%), 2021–2032

5.2 Global Semi-Solid Dose Sales Volume by Region

5.2.1 Global Semi-Solid Dose Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Semi-Solid Dose Sales Volume by Region (2021–2026)

5.2.3 Global Semi-Solid Dose Sales Volume by Region (2027–2032)

5.2.4 Global Semi-Solid Dose Sales Volume by Region (%), 2021–2032

5.3 Global Semi-Solid Dose Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Semi-Solid Dose Sales Value, 2021–2032

5.4.2 North America Semi-Solid Dose Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Semi-Solid Dose Sales Value, 2021–2032

5.5.2 Europe Semi-Solid Dose Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Semi-Solid Dose Sales Value, 2021–2032

5.6.2 Asia Pacific Semi-Solid Dose Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Semi-Solid Dose Sales Value, 2021–2032

5.7.2 South America Semi-Solid Dose Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Semi-Solid Dose Sales Value, 2021–2032

5.8.2 Middle East & Africa Semi-Solid Dose Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Semi-Solid Dose Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Semi-Solid Dose Sales Value and Sales Volume

6.2.1 Key Countries/Regions Semi-Solid Dose Sales Value, 2021–2032

6.2.2 Key Countries/Regions Semi-Solid Dose Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Semi-Solid Dose Sales Value, 2021–2032

6.3.2 United States Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Semi-Solid Dose Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Semi-Solid Dose Sales Value, 2021–2032

6.4.2 Europe Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Semi-Solid Dose Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Semi-Solid Dose Sales Value, 2021–2032

6.5.2 China Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

6.5.3 China Semi-Solid Dose Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Semi-Solid Dose Sales Value, 2021–2032

6.6.2 Japan Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Semi-Solid Dose Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Semi-Solid Dose Sales Value, 2021–2032

6.7.2 South Korea Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Semi-Solid Dose Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Semi-Solid Dose Sales Value, 2021–2032

6.8.2 Southeast Asia Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Semi-Solid Dose Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Semi-Solid Dose Sales Value, 2021–2032

6.9.2 India Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

6.9.3 India Semi-Solid Dose Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Johnson & Johnson

7.1.1 Johnson & Johnson Company Information

7.1.2 Johnson & Johnson Introduction and Business Overview

7.1.3 Johnson & Johnson Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Johnson & Johnson Semi-Solid Dose Product Offerings

7.1.5 Johnson & Johnson Recent Developments

7.2 Merck & Co

7.2.1 Merck & Co Company Information

7.2.2 Merck & Co Introduction and Business Overview

7.2.3 Merck & Co Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Merck & Co Semi-Solid Dose Product Offerings

7.2.5 Merck & Co Recent Developments

7.3 Bayer AG

7.3.1 Bayer AG Company Information

7.3.2 Bayer AG Introduction and Business Overview

7.3.3 Bayer AG Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Bayer AG Semi-Solid Dose Product Offerings

7.3.5 Bayer AG Recent Developments

7.4 Hisamitsu Pharmaceutical

7.4.1 Hisamitsu Pharmaceutical Company Information

7.4.2 Hisamitsu Pharmaceutical Introduction and Business Overview

7.4.3 Hisamitsu Pharmaceutical Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Hisamitsu Pharmaceutical Semi-Solid Dose Product Offerings

7.4.5 Hisamitsu Pharmaceutical Recent Developments

7.5 Glenmark Pharmaceuticals

7.5.1 Glenmark Pharmaceuticals Company Information

7.5.2 Glenmark Pharmaceuticals Introduction and Business Overview

7.5.3 Glenmark Pharmaceuticals Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 Glenmark Pharmaceuticals Semi-Solid Dose Product Offerings

7.5.5 Glenmark Pharmaceuticals Recent Developments

7.6 Cipla Ltd

7.6.1 Cipla Ltd Company Information

7.6.2 Cipla Ltd Introduction and Business Overview

7.6.3 Cipla Ltd Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Cipla Ltd Semi-Solid Dose Product Offerings

7.6.5 Cipla Ltd Recent Developments

7.7 Nestle SA

7.7.1 Nestle SA Company Information

7.7.2 Nestle SA Introduction and Business Overview

7.7.3 Nestle SA Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Nestle SA Semi-Solid Dose Product Offerings

7.7.5 Nestle SA Recent Developments

7.8 Novartis AG

7.8.1 Novartis AG Company Information

7.8.2 Novartis AG Introduction and Business Overview

7.8.3 Novartis AG Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 Novartis AG Semi-Solid Dose Product Offerings

7.8.5 Novartis AG Recent Developments

7.9 GlaxoSmithKline plc

7.9.1 GlaxoSmithKline plc Company Information

7.9.2 GlaxoSmithKline plc Introduction and Business Overview

7.9.3 GlaxoSmithKline plc Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 GlaxoSmithKline plc Semi-Solid Dose Product Offerings

7.9.5 GlaxoSmithKline plc Recent Developments

7.10 Bausch Health Companies

7.10.1 Bausch Health Companies Company Information

7.10.2 Bausch Health Companies Introduction and Business Overview

7.10.3 Bausch Health Companies Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2021–2026)

7.10.4 Bausch Health Companies Semi-Solid Dose Product Offerings

7.10.5 Bausch Health Companies Recent Developments

8 Industry Chain Analysis

8.1 Semi-Solid Dose Industrial Chain

8.2 Semi-Solid Dose Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Semi-Solid Dose Sales Model

8.5.2 Sales Channels

8.5.3 Semi-Solid Dose Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Semi-Solid Dose Market Trends

Table 2. Semi-Solid Dose Market Drivers & Opportunities

Table 3. Semi-Solid Dose Market Challenges

Table 4. Semi-Solid Dose Market Restraints

Table 5. Global Semi-Solid Dose Revenue by Company (US$ Million), 2021–2026

Table 6. Global Semi-Solid Dose Revenue Market Share by Company (2021–2026)

Table 7. Global Semi-Solid Dose Sales Volume by Company (Tons), 2021–2026

Table 8. Global Semi-Solid Dose Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Semi-Solid Dose Price by Company (US$/Ton), 2021–2026

Table 10. Key Manufacturers Semi-Solid Dose Manufacturing Base and Headquarters

Table 11. Key Manufacturers Semi-Solid Dose Product Type

Table 12. Key Manufacturers Start of Mass Production of Semi-Solid Dose

Table 13. Global Semi-Solid Dose Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Semi-Solid Dose revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Semi-Solid Dose Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Semi-Solid Dose Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Semi-Solid Dose Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Semi-Solid Dose Sales Market Share in Value by Type (2021–2026)

Table 20. Global Semi-Solid Dose Sales Market Share in Value by Type (2027–2032)

Table 21. Global Semi-Solid Dose Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons)

Table 22. Global Semi-Solid Dose Sales Volume by Type (Tons), 2021–2026

Table 23. Global Semi-Solid Dose Sales Volume by Type (Tons), 2027–2032

Table 24. Global Semi-Solid Dose Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Semi-Solid Dose Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Semi-Solid Dose Price by Type (US$/Ton), 2021–2026

Table 27. Global Semi-Solid Dose Price by Type (US$/Ton), 2027–2032

Table 28. Global Semi-Solid Dose Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Semi-Solid Dose Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Semi-Solid Dose Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Semi-Solid Dose Sales Market Share in Value by Application (2021–2026)

Table 32. Global Semi-Solid Dose Sales Market Share in Value by Application (2027–2032)

Table 33. Global Semi-Solid Dose Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)

Table 34. Global Semi-Solid Dose Sales Volume by Application (Tons), 2021–2026

Table 35. Global Semi-Solid Dose Sales Volume by Application (Tons), 2027–2032

Table 36. Global Semi-Solid Dose Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Semi-Solid Dose Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Semi-Solid Dose Price by Application (US$/Ton), 2021–2026

Table 39. Global Semi-Solid Dose Price by Application (US$/Ton), 2027–2032

Table 40. Global Semi-Solid Dose Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Semi-Solid Dose Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Semi-Solid Dose Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Semi-Solid Dose Sales Value by Region (%), 2021–2026

Table 44. Global Semi-Solid Dose Sales Value by Region (%), 2027–2032

Table 45. Global Semi-Solid Dose Sales Volume by Region (Tons): 2021 vs 2025 vs 2032

Table 46. Global Semi-Solid Dose Sales Volume by Region (Tons), 2021–2026

Table 47. Global Semi-Solid Dose Sales Volume by Region (Tons), 2027–2032

Table 48. Global Semi-Solid Dose Sales Volume by Region (%), 2021–2026

Table 49. Global Semi-Solid Dose Sales Volume by Region (%), 2027–2032

Table 50. Global Semi-Solid Dose Average Price by Region (US$/Ton), 2021–2026

Table 51. Global Semi-Solid Dose Average Price by Region (US$/Ton), 2027–2032

Table 52. Key Countries/Regions Semi-Solid Dose Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Semi-Solid Dose Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Semi-Solid Dose Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Semi-Solid Dose Sales Volume, (Tons), 2021–2026

Table 56. Key Countries/Regions Semi-Solid Dose Sales Volume, (Tons), 2027–2032

Table 57. Johnson & Johnson Company Information

Table 58. Johnson & Johnson Introduction and Business Overview

Table 59. Johnson & Johnson Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 60. Johnson & Johnson Semi-Solid Dose Product Offerings

Table 61. Johnson & Johnson Recent Developments

Table 62. Merck & Co Company Information

Table 63. Merck & Co Introduction and Business Overview

Table 64. Merck & Co Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 65. Merck & Co Semi-Solid Dose Product Offerings

Table 66. Merck & Co Recent Developments

Table 67. Bayer AG Company Information

Table 68. Bayer AG Introduction and Business Overview

Table 69. Bayer AG Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 70. Bayer AG Semi-Solid Dose Product Offerings

Table 71. Bayer AG Recent Developments

Table 72. Hisamitsu Pharmaceutical Company Information

Table 73. Hisamitsu Pharmaceutical Introduction and Business Overview

Table 74. Hisamitsu Pharmaceutical Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 75. Hisamitsu Pharmaceutical Semi-Solid Dose Product Offerings

Table 76. Hisamitsu Pharmaceutical Recent Developments

Table 77. Glenmark Pharmaceuticals Company Information

Table 78. Glenmark Pharmaceuticals Introduction and Business Overview

Table 79. Glenmark Pharmaceuticals Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 80. Glenmark Pharmaceuticals Semi-Solid Dose Product Offerings

Table 81. Glenmark Pharmaceuticals Recent Developments

Table 82. Cipla Ltd Company Information

Table 83. Cipla Ltd Introduction and Business Overview

Table 84. Cipla Ltd Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 85. Cipla Ltd Semi-Solid Dose Product Offerings

Table 86. Cipla Ltd Recent Developments

Table 87. Nestle SA Company Information

Table 88. Nestle SA Introduction and Business Overview

Table 89. Nestle SA Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 90. Nestle SA Semi-Solid Dose Product Offerings

Table 91. Nestle SA Recent Developments

Table 92. Novartis AG Company Information

Table 93. Novartis AG Introduction and Business Overview

Table 94. Novartis AG Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 95. Novartis AG Semi-Solid Dose Product Offerings

Table 96. Novartis AG Recent Developments

Table 97. GlaxoSmithKline plc Company Information

Table 98. GlaxoSmithKline plc Introduction and Business Overview

Table 99. GlaxoSmithKline plc Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 100. GlaxoSmithKline plc Semi-Solid Dose Product Offerings

Table 101. GlaxoSmithKline plc Recent Developments

Table 102. Bausch Health Companies Company Information

Table 103. Bausch Health Companies Introduction and Business Overview

Table 104. Bausch Health Companies Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 105. Bausch Health Companies Semi-Solid Dose Product Offerings

Table 106. Bausch Health Companies Recent Developments

Table 107. Key Raw Materials Lists

Table 108. Key Suppliers of Raw Materials Lists

Table 109. Semi-Solid Dose Downstream Customers

Table 110. Semi-Solid Dose Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Semi-Solid Dose Product Picture

Figure 2. Global Semi-Solid Dose Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 4. Global Semi-Solid Dose Sales Volume (Tons), 2021–2032

Figure 5. Global Semi-Solid Dose Sales Price (US$/Ton), 2021–2032

Figure 6. Semi-Solid Dose Report Years Considered

Figure 7. Global Semi-Solid Dose Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Semi-Solid Dose Sales Volume Ranking of Players (Tons), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Semi-Solid Dose Revenue in 2025

Figure 10. Semi-Solid Dose Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Ointments Picture

Figure 12. Pastes Picture

Figure 13. Gels Picture

Figure 14. Global Semi-Solid Dose Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Semi-Solid Dose Sales Value Market Share by Type, 2025 & 2032

Figure 16. Global Semi-Solid Dose Sales Volume by Type (Tons), 2021 vs 2025 vs 2032

Figure 17. Global Semi-Solid Dose Sales Volume Market Share by Type, 2025 & 2032

Figure 18. Global Semi-Solid Dose Price by Type (US$/Ton), 2021–2032

Figure 19. Product Picture of Skin

Figure 20. Product Picture of Nasal Cavity

Figure 21. Product Picture of Vaginal Cavity

Figure 22. Product Picture of Rectal Cavity

Figure 23. Product Picture of Others

Figure 24. Global Semi-Solid Dose Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 25. Global Semi-Solid Dose Sales Value Market Share by Application, 2025 & 2032

Figure 26. Global Semi-Solid Dose Sales Volume by Application (Tons), 2021 vs 2025 vs 2032

Figure 27. Global Semi-Solid Dose Sales Volume Market Share by Application, 2025 & 2032

Figure 28. Global Semi-Solid Dose Price by Application (US$/Ton), 2021–2032

Figure 29. North America Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 30. North America Semi-Solid Dose Sales Value by Country (%), 2025 vs 2032

Figure 31. Europe Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 32. Europe Semi-Solid Dose Sales Value by Country (%), 2025 vs 2032

Figure 33. Asia Pacific Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 34. Asia Pacific Semi-Solid Dose Sales Value by Region (%), 2025 vs 2032

Figure 35. South America Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 36. South America Semi-Solid Dose Sales Value by Country (%), 2025 vs 2032

Figure 37. Middle East & Africa Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 38. Middle East & Africa Semi-Solid Dose Sales Value by Country (%), 2025 vs 2032

Figure 39. Key Countries/Regions Semi-Solid Dose Sales Value (%), 2021–2032

Figure 40. Key Countries/Regions Semi-Solid Dose Sales Volume (%), 2021–2032

Figure 41. United States Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 42. United States Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

Figure 43. United States Semi-Solid Dose Sales Value by Application (%), 2025 vs 2032

Figure 44. Europe Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 45. Europe Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

Figure 46. Europe Semi-Solid Dose Sales Value by Application (%), 2025 vs 2032

Figure 47. China Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 48. China Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

Figure 49. China Semi-Solid Dose Sales Value by Application (%), 2025 vs 2032

Figure 50. Japan Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 51. Japan Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

Figure 52. Japan Semi-Solid Dose Sales Value by Application (%), 2025 vs 2032

Figure 53. South Korea Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 54. South Korea Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

Figure 55. South Korea Semi-Solid Dose Sales Value by Application (%), 2025 vs 2032

Figure 56. Southeast Asia Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 57. Southeast Asia Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

Figure 58. Southeast Asia Semi-Solid Dose Sales Value by Application (%), 2025 vs 2032

Figure 59. India Semi-Solid Dose Sales Value (US$ Million), 2021–2032

Figure 60. India Semi-Solid Dose Sales Value by Type (%), 2025 vs 2032

Figure 61. India Semi-Solid Dose Sales Value by Application (%), 2025 vs 2032

Figure 62. Semi-Solid Dose Industrial Chain

Figure 63. Semi-Solid Dose Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Semi-Solid Dose market? zhanKai

The top companies in the global Semi-Solid Dose market are Johnson & Johnson、Merck & Co、Bayer AG.

Related Reports

Global Semi-Solid Dose Market Research Report 2026
The global Semi-Solid Dose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-01
Pages: 130
USD 2900.00
(Single User License)
Global Semi-Solid Dose Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Semi-Solid Dose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 142
USD 4900.00
(Single User License)
Semi-Solid Dose- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 99
USD 3950.00
(Single User License)
Global Semi-Solid Dose Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Semi-Solid Dose market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 76
USD 4250.00
(Single User License)
Global Semi-Solid Dose Market Research Report 2025
The global market for Semi-Solid Dose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-14
Pages: 94
USD 2900.00
(Single User License)
Global Semi-Solid Dose Market Insights, Forecast to 2030
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
Global Semi-Solid Dose Market Research Report 2024
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-02-14
Pages: 98
USD 2900.00
(Single User License)
Semi-Solid Dose - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-01-04
Pages: 130
USD 3950.00
(Single User License)

Global Semi-Solid Dose Market Research Report 2026
The global Semi-Solid Dose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-01
Pages: 130
USD 2900.00 (Single User License)
Global Semi-Solid Dose Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Semi-Solid Dose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 142
USD 4900.00 (Single User License)
Semi-Solid Dose- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 99
USD 3950.00 (Single User License)
Global Semi-Solid Dose Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Semi-Solid Dose market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 76
USD 4250.00 (Single User License)
Global Semi-Solid Dose Market Research Report 2025
The global market for Semi-Solid Dose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 94
USD 2900.00 (Single User License)
Global Semi-Solid Dose Market Insights, Forecast to 2030
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-04-10
Pages: 112
USD 4900.00 (Single User License)
Global Semi-Solid Dose Market Research Report 2024
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-02-14
Pages: 98
USD 2900.00 (Single User License)
Semi-Solid Dose - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-01-04
Pages: 130
USD 3950.00 (Single User License)